Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 5, 1987
Grant Date -
N/A
app pub date -
Apr 19, 1985
filing date -
Apr 26, 1984
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The use of etilefrin or etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia, such as for example peripheral arterial stenoses, leads surprisingly to a continuous stable rise in systolic blood pressure and blood pressure amplitude and an improved cardiac output, without affecting the diastolic blood pressure or the cardiac frequency. The pharmaceutical effect is enhanced by using etilefrin in combination with an extract of horse chestnut seeds in a long term treatment.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully